American Capital Management Inc Repligen Corp Transaction History

American Capital Management Inc

$3.11 Billion
Q1 2024

A detailed history of American Capital Management Inc transactions in Repligen Corp stock. As of the latest transaction made, American Capital Management Inc holds 227,310 shares of RGEN stock, worth $27.2 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

227,310

Previous 232,552 2.25%

Holding current value

$27.2 Million

Previous $41.8 Million 0.01%

% of portfolio

1.34%

Previous 1.44%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $895,228 - $1.09 Million	-5,242 Reduced 2.25%	227,310 $41.8 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $485,565 - $788,293	4,253 Added 1.86%	232,552 $41.8 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $14,155 - $18,004	-102 Reduced 0.04%	228,299 $36.3 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $7.74 Million - $10.1 Million	55,904 Added 32.41%	228,401 $32.3 Million
Q1 2023 May 03, 2023	BUY	$154.26 - $198.1 $4.9 Million - $6.29 Million	31,746 Added 22.55%	172,497 $29 Million

Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $2.9 Million - $3.93 Million	17,827 Added 14.5%	140,751 $23.8 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $764,080 - $1.22 Million	-4,763 Reduced 3.73%	122,924 $23 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $1.81 Million - $2.42 Million	12,873 Added 11.21%	127,687 $20.7 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $590,277 - $944,649	3,662 Added 3.29%	114,814 $21.6 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $212,432 - $261,235	-858 Reduced 0.77%	111,152 $29.4 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $354,286 - $589,737	-1,819 Reduced 1.6%	112,010 $32.4 Million
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $154,259 - $205,483	930 Added 0.82%	113,829 $22.7 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $591,793 - $742,359	3,281 Added 2.99%	112,899 $21.9 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $91,217 - $127,247	616 Added 0.57%	109,618 $21 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $51,821 - $66,948	423 Added 0.39%	109,002 $16.1 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $208,469 - $310,460	-2,210 Reduced 1.99%	108,579 $13.4 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $3.21 Million - $4.12 Million	37,774 Added 51.73%	110,789 $10.7 Million
Q4 2019 Feb 12, 2020	BUY	$73.84 - $93.08 $25,844 - $32,578	350 Added 0.48%	73,015 $6.75 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $11,880 - $14,804	155 Added 0.21%	72,665 $5.57 Million
Q2 2019 Aug 12, 2019	SELL	$54.2 - $85.95 $44,986 - $71,338	-830 Reduced 1.13%	72,510 $6.23 Million
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $131,784 - $167,362	2,665 Added 3.77%	73,340 $4.33 Million
Q4 2018 Feb 08, 2019	BUY	$48.26 - $68.88 $46,329 - $66,124	960 Added 1.38%	70,675 $3.73 Million
Q3 2018 Nov 02, 2018	BUY	$46.8 - $58.97 $3.26 Million - $4.11 Million	69,715 New	69,715 $3.87 Million

Others Institutions Holding RGEN

# of Institutions

521

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.65B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Management Inc with notifications on news.

Account

American Capital Management Inc Repligen Corp Transaction History